본문으로 건너뛰기
← 뒤로

MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.

Heliyon 2024 Vol.10(9) p. e30599

Tolue Ghasaban F, Ghanei M, Mahmoudian RA, Taghehchian N, Abbaszadegan MR, Moghbeli M

📝 환자 설명용 한 줄

Pancreatic cancer (PC), as one of the main endocrine and digestive systems malignancies has the highest cancer related mortality in the world.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Tolue Ghasaban F, Ghanei M, et al. (2024). MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.. Heliyon, 10(9), e30599. https://doi.org/10.1016/j.heliyon.2024.e30599
MLA Tolue Ghasaban F, et al.. "MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.." Heliyon, vol. 10, no. 9, 2024, pp. e30599.
PMID 38726188

Abstract

Pancreatic cancer (PC), as one of the main endocrine and digestive systems malignancies has the highest cancer related mortality in the world. Lack of the evident clinical symptoms and appropriate diagnostic markers in the early stages of tumor progression are the main reasons of the high mortality rate among PC patients. Therefore, it is necessary to investigate the molecular pathways involved in the PC progression, in order to introduce novel early diagnostic methods. Epithelial mesenchymal transition (EMT) is a critical cellular process associated with pancreatic tumor cells invasion and distant metastasis. MicroRNAs (miRNAs) are also important regulators of EMT process. In the present review, we discussed the role of miRNAs in regulation of EMT process during PC progression. It has been reported that the miRNAs mainly regulate the EMT process in pancreatic tumor cells through the regulation of EMT-specific transcription factors and several signaling pathways such as WNT, NOTCH, TGF-β, JAK/STAT, and PI3K/AKT. Considering the high stability of miRNAs in body fluids and their role in regulation of EMT process, they can be introduced as the non-invasive diagnostic markers in the early stages of malignant pancreatic tumors. This review paves the way to introduce a non-invasive EMT based panel marker for the early tumor detection among PC patients.